Results 131 to 140 of about 9,113,589 (351)

Crohn's Disease of the Stomach? [PDF]

open access: bronze, 1965
Gabriel A. Kune, Jane M. Fullerton
openalex   +1 more source

Electroacupuncture reshapes the microbial co‐occurrence networks related to the behavioral and psychological symptoms of dementia in Alzheimer's disease

open access: yesiMetaOmics, EarlyView.
Microbial keystone species and gut microbiota composition are highly variable during the pathological development of the behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD). Age stratification reveals stage‐specific gut microbial signatures in AD‐related BPSD.
Fu‐You Su   +7 more
wiley   +1 more source

Role of MR enterography in acute and chronic stages of Crohn's disease

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2018
Background: Crohn's disease (CD) is an autoimmune disease affecting young, adult with relapsing course. MRI is now considered a safe alternative for, diagnosing complication of Crohn s disease.
Rabab Yasin   +2 more
doaj  

Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. [PDF]

open access: bronze, 1968
A. Victor Hoffbrand   +3 more
openalex   +1 more source

Chinese herbal medicine‐derived extracellular vesicle‐like particles: Therapeutic potential and future research approaches

open access: yesInterdisciplinary Medicine, EarlyView.
This article evaluates the therapeutic potential of extracellular vesicle‐like particles derived from Chinese herbal medicine (CHM‐EVLP) for a range of diseases. It underscores the significance of traditional Chinese medicine in the development of innovative formulations.
Ying‐qi Cao   +6 more
wiley   +1 more source

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

open access: yesNature Genetics, 2008
J. Barrett   +62 more
semanticscholar   +1 more source

Crohn??s Disease [PDF]

open access: yesJournal of Occupational and Environmental Medicine, 1968
openaire   +4 more sources

Leveraging interprofessional team‐based care in an IBD clinic to transition patients from intravenous to subcutaneous risankizumab‐rzaa

open access: yesJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
Abstract There are no data evaluating the success rate in transitioning intravenous (IV) to subcutaneous (SQ) risankizumab‐rzaa. To address these challenges, the University of Chicago Medicine (UCM) utilized an interprofessional team‐based, pharmacist‐directed follow‐up strategy to ensure patients initiate and maintain therapy.
David Choi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy